Treatment-resistant depression

Disease1 paper

Trial sponsors

Eli Lilly and Company
Company2 trialsPhase 31,068 people
AstraZeneca
Company1 trialPhase 3688 people
Washington University School of Medicine
2 trialsPhase 4782 people
Centre for Addiction and Mental Health
2 trialsPhase 4163 people
Theresa Jacob, PhD, MPH
1 trialPhase 415 people
Pakistan Institute of Living and Learning
1 trialPhase 3150 people
Jessica Harder
1 trialPhase 232 people

Latest

1

Drug Design, Development and TherapyReview31 Aug

A Staged Translational Framework for Evaluating Oral Glutamatergic and Senescence-Modulating Strategies in Treatment-Resistant Depression